2026 David W. Grainger: Materials Science Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Materials Science	70	4409	4266	1178	1109	276	18558
Chemistry	68	6518	5913	1981	1647	243	16729

Research.com Recognitions

2008 - Fellow of Biomaterials Science and Engineering
2008 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David W. Grainger is affiliated with the University of Utah in the United States. Their research spans the field of Medicine, with a focus on several subfields including Genetics, Surgery, Biomedical Engineering, Biomaterials, and Molecular Biology.

The main topics of their work include:

Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Osteoarthritis Treatment and Mechanisms
Electrospun Nanofibers in Biomedical Applications
3D Printing in Biomedical Research
Periodontal Regeneration and Treatments
Knee injuries and reconstruction techniques

Their frequent co-authors are:

Teruo Okano
Kyung-Sook Kim
Makoto Kondō
Sumako Kameishi
Sophia Bou-Ghannam

Publishing regularly in several journals, the most common venues for their work include:

Scientific Reports
Cells
Journal of Controlled Release
Advanced Drug Delivery Reviews
Journal of the American Medical Informatics Association

Representative recent papers authored or co-authored by David W. Grainger include:

Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies, 2021, Acta Biomaterialia
3D cell sheet structure augments mesenchymal stem cell cytokine production, 2021, Scientific Reports
Trends in Articular Cartilage Tissue Engineering: 3D Mesenchymal Stem Cell Sheets as Candidates for Engineered Hyaline-Like Cartilage, 2021, Cells
Regulatory Considerations Specific to Liposome Drug Development as Complex Drug Products, 2022, Frontiers in Drug Delivery
Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation, 2022, Advanced Drug Delivery Reviews

David W. Grainger was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2008 and also as a Fellow of Biomaterials Science and Engineering in the same year.

Best Publications

X-ray photoelectron spectroscopy sulfur 2p study of organic thiol and disulfide binding interactions with gold surfaces

David G. Castner;Kenneth Hinds;David W. Grainger

1624
Citations
Nanoparticle Uptake: The Phagocyte Problem.

Heather Herd Gustafson;Dolly Holt-Casper;David W. Grainger;Hamidreza Ghandehari

1420
Citations
Biomaterial-Associated Infection: Locating the Finish Line in the Race for the Surface

Henk J. Busscher;Henny C. van der Mei;Guruprakash Subbiahdoss;Paul C. Jutte

790
Citations
In vitro assessments of nanomaterial toxicity

Clinton F. Jones;David W. Grainger

706
Citations
Drug/device combinations for local drug therapies and infection prophylaxis.

Peng Wu;David W. Grainger

619
Citations
Extracellular matrix-based biomaterial scaffolds and the host response

Joseph M. Aamodt;David W. Grainger

525
Citations
A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity

Anna Astashkina;Brenda Mann;David W. Grainger

510
Citations
Surface Coverage and Structure of Mixed DNA/Alkylthiol Monolayers on Gold: Characterization by XPS, NEXAFS, and Fluorescence Intensity Measurements

Chi Ying Lee;Ping Gong;Gregory M. Harbers;David W. Grainger

322
Citations
Modulating fibroblast adhesion, spreading, and proliferation using self-assembled monolayer films of alkylthiolates on gold.

Kristin B. McClary;Tatiana Ugarova;David W. Grainger

275
Citations
Nanoparticles in medicine: Current challenges facing inorganic nanoparticle toxicity assessments and standardizations

Margarethe Hofmann-Amtenbrink;David W. Grainger;Heinrich Hofmann

254
Citations
Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments

Anna Astashkina;David W. Grainger

242
Citations
All charged up about implanted biomaterials

David W Grainger

231
Citations
In vivo human time-exposure study of orally dosed commercial silver nanoparticles

Mark A. Munger;Przemyslaw Radwanski;Greg C. Hadlock;Greg Stoddard

229
Citations
Cationic PAMAM dendrimers aggressively initiate blood clot formation.

Clinton F. Jones;Robert A. Campbell;Amanda E. Brooks;Shoeleh Assemi

227
Citations
Nanobiomaterials and Nanoanalysis : Opportunities for Improving the Science to Benefit Biomedical Technologies

David W. Grainger;David G. Castner

227
Citations
Fabrication of poly(α‐hydroxy acid) foam scaffolds using multiple solvent systems

Yunhua Hu;David W. Grainger;Shelley R. Winn;Jeffrey O. Hollinger

225
Citations
Localized immunosuppressive environment in the foreign body response to implanted biomaterials.

David M. Higgins;Randall J. Basaraba;April C. Hohnbaum;Eric J. Lee

220
Citations
A critical comparison of protein microarray fabrication technologies.

Valentin Romanov;S. Nikki Davidoff;Adam R. Miles;David W. Grainger

212
Citations
Structure and Frictional Properties of Self-Assembled Surfactant Monolayers

Yihan Liu and;D. Fennell Evans;Qun Song and;David W. Grainger

212
Citations
DNA and protein microarray printing on silicon nitride waveguide surfaces

Peng Wu;Paul Hogrebe;David W. Grainger

186
Citations